Joan M. Blonder

ProJuvant™ (Pluronic F127®/chitosan) enhances the immune response to intranasally administered tetanus toxoid

M.A. Julie Westerink, S. Louise Smithson, N C Srivastava et al. · Vaccine · 2001 · 83 citations

Inflammation, Tetanus Toxoid, Medicine +8

Pluronic® F127-based systemic vaccine delivery systems

Claire Coeshott, S. Louise Smithson, Evie L. Verderber et al. · Vaccine · 2004 · 82 citations

Vaccination, Mucosal Vaccination, Cross-protection +7

Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel

Joan M. Blonder, Linda Baird, Jon C. Fulfs et al. · Life Sciences · 1999 · 75 citations

Dose-dependent Hyperlipidemia, Medicine, Physiology +4

Multiple endocrine neoplasia (MEN) syndrome type IIB: gastrointestinal manifestations

Demos Tc, Joan M. Blonder, WL Schey et al. · American Journal of Roentgenology · 1983 · 41 citations

Endocrine Oncology, Tongue Nodules, Syndrome Type Iib +13

Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice

Simon N. Robinson, Jennifer Chavez, R. Lee Mosley et al. · Bone Marrow Transplantation · 2003 · 32 citations

Cell-based Drug Delivery, Nanomedicine, Drug Targeting +9